Mendus AB (publ)
STO:IMMU
Mendus AB (publ)
STO:IMMU
Price:
5.19
SEK
-0.19%
Market Cap:
kr316.3m
Relative Value
The Relative Value of one
IMMU
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 5.19 SEK,
Mendus AB (publ)
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IMMU Relative Value
HIDDEN
Multiples Across Competitors
IMMU Competitors Multiples
Mendus AB (publ) Competitors
Mendus AB (publ) Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Mendus AB (publ)
STO:IMMU
|
316.3m SEK | 0 | -3.1 | -2.9 | -2.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
401.5B USD | 6.7 | 169.9 | 16.4 | 23.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.1B USD | 5.1 | 26 | 18.6 | 18.6 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.9B USD | 6.1 | 21.9 | 14.9 | 14.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.4B USD | 10.1 | 32.2 | 23.6 | 24.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.1B USD | 5.6 | 17.7 | 15 | 17.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
87.7B AUD | 3.9 | 20.3 | 13.6 | 16.9 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44.5B EUR | 14.6 | 34.4 | 58.8 | 60.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
